CS logo
small CS logo
Sibley Memorial Hospital

Washington, District of Columbia, United States
Hospital in Washington, D.C.
5255 Loughboro Rd NW, Washington, DC 20016
318 Beds

About Sibley Memorial Hospital


Sibley Memorial Hospital is a non-profit hospital located in The Palisades neighborhood of Washington, D.C. It is fully accredited by the Joint Commission on Accreditation of Healthcare Organizations, and is licensed by the District of Columbia Department of Health and Human Services.
There are 318 beds in Sibley Memorial Hospital.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Sibley Memorial Hospital


During the past decade, Sibley Memorial Hospital conducted 117 clinical trials. In the 10-year time frame, 117 clinical trials started and 85 clinical trials were completed, i.e. on average, 72.6% percent of trials that started reached the finish line to date. In the past 5 years, 36 clinical trials started and 56 clinical trials were completed. i.e. 155.6% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Sibley Memorial Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 59 trials, followed by "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins" with 27 trials sponsored, "Alliance for Clinical Trials in Oncology" with 17 trials sponsored, "SWOG Cancer Research Network" with 16 trials sponsored and "NSABP Foundation Inc" with 16 trials sponsored. Other sponsors include 71 different institutions and companies that sponsored additional 48 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Sibley Memorial Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 72 trials as a collaborator, "NRG Oncology" with 14 trials as a collaborator, "Canadian Cancer Trials Group" with 10 trials as a collaborator, "NCIC Clinical Trials Group" with 9 trials as a collaborator and "SWOG Cancer Research Network" with 8 trials as a collaborator. Other collaborators include 140 different institutions and companies that were collaborators in the rest 106 trials.

Clinical Trials Conditions at Sibley Memorial Hospital


According to Clinical.Site data, the most researched conditions in "Sibley Memorial Hospital" are "Breast Cancer" (28 trials), "Prostate Cancer" (14 trials), "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Invasive Breast Carcinoma" (7 trials) and "Recurrent Breast Carcinoma" (7 trials). Many other conditions were trialed in "Sibley Memorial Hospital" in a lesser frequency.

Clinical Trials Intervention Types at Sibley Memorial Hospital


Most popular intervention types in "Sibley Memorial Hospital" are "Drug" (154 trials), "Other" (98 trials), "Biological" (59 trials), "Radiation" (39 trials) and "Procedure" (31 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (51 trials), "Quality-of-Life Assessment" (33 trials), "Paclitaxel" (24 trials), "Questionnaire Administration" (21 trials) and "Carboplatin" (20 trials). Other intervention names were less common.

Clinical Trials Genders at Sibley Memorial Hospital


The vast majority of trials in "Sibley Memorial Hospital" are 123 trials for "All" genders, 57 trials for "Female" genders and 25 trials for "Male" genders.

Clinical Trials Status at Sibley Memorial Hospital


Currently, there are NaN active trials in "Sibley Memorial Hospital". 1 are not yet recruiting, 38 are recruiting, 79 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 65 completed trials in Sibley Memorial Hospital, 1 suspended trials, and 15 terminated clinical trials to date.
Out of the total trials that were conducted in Sibley Memorial Hospital, 14 "Phase 1" clinical trials were conducted, 81 "Phase 2" clinical trials and 96 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 16 trials that are defined as “Not Applicable".